...
首页> 外文期刊>Journal of the Iranian Chemical Society >Exploring the interaction between 'site-markers, aspirin and esterase-like activity' ternary systems on the human serum albumin: direct evidence for modulation of catalytic activity of the protein in different inhibition modes
【24h】

Exploring the interaction between 'site-markers, aspirin and esterase-like activity' ternary systems on the human serum albumin: direct evidence for modulation of catalytic activity of the protein in different inhibition modes

机译:探讨人血清白蛋白的“位点标记,阿司匹林和酯酶样活性”三元系统之间的相互作用:不同抑制模式下蛋白质催化活性的直接证据

获取原文
获取原文并翻译 | 示例
           

摘要

Albumin which is the most abundant drug carrier protein in plasma controls the distribution aspect of drug pharmacokinetics. The aim of this study has been to elucidate the concurrent binding behavior of indomethacin/ibuprofen/heme to HSA under the effect of aspirin-mediated protein acetylation and also to explore the esterase-like catalytic property of the unmodified/modified proteins, as binary or ternary systems, by using various spectroscopic and molecular docking techniques. We found that aspirin-based modification of HSA affects the protein conformation as well as ligand binding at sites I-III. Decrease in pNPA-mediated esterase activity of HSA in different reversible inhibition modes, upon the protein-ligand interactions, was also documented, an issue that may receive considerable attention for computational prodrug design in near future.
机译:白蛋白是等离子体中最丰富的药物载体蛋白质控制药物药代动力学的分布方面。 本研究的目的是在阿司匹林介导的蛋白乙酰化的作用下阐明吲哚美辛/布洛芬/血红素到HSA的并发结合行为,也可以探讨未修饰/改性蛋白质的酯酶样催化性能,如二元或 三元系统,通过使用各种光谱和分子对接技术。 我们发现HSA的阿司匹林的改性会影响蛋白质构象以及位点I-III的配体结合。 在蛋白质 - 配体相互作用上,蛋白质 - 配体相互作用的不同可逆抑制模式中HSA的PNPA介导的酯酶活性的降低还记录了可能在不久的将来可能获得相当关注的计算前提设计的问题。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号